CellSource Co (TSE:4880) EBIT per Share : 円57.51 (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co EBIT per Share?

CellSource Co's EBIT per Share for the three months ended in Jan. 2024 was 円10.71. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was 円57.51.

During the past 12 months, the average EBIT per Share Growth Rate of CellSource Co was -36.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 42.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 31.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CellSource Co's EBIT per Share or its related term are showing as below:

TSE:4880' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 31.4 Med: 38 Max: 48.4
Current: 42.9

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of CellSource Co was 48.40% per year. The lowest was 31.40% per year. And the median was 38.00% per year.

TSE:4880's 3-Year EBIT Growth Rate is ranked better than
89.95% of 1304 companies
in the Biotechnology industry
Industry Median: 3.6 vs TSE:4880: 42.90

CellSource Co's EBIT for the three months ended in Jan. 2024 was 円213 Mil.

CellSource Co EBIT per Share Historical Data

The historical data trend for CellSource Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co EBIT per Share Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

EBIT per Share

Get a 7-Day Free Trial

23.23

21.60

52.40

82.43

64.39

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT per Share	Get a 7-Day Free Trial															17.67	16.62	22.17	8.01	10.71

CellSource Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CellSource Co's EBIT per Share for the fiscal year that ended in Oct. 2023 is calculated as

	EBIT per Share		(A: Oct. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1240.061	/	19.260
=	64.39

CellSource Co's EBIT per Share for the quarter that ended in Jan. 2024 is calculated as

	EBIT per Share		(Q: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	213.087	/	19.903
=	10.71

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円57.51

CellSource Co (TSE:4880) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CellSource Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of CellSource Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines